Candel Therapeutics, Inc. Intellectual Property Contracts & Agreements

6 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Exclusive License Agreement by and between Candel Therapeutics, Inc. and Periphagen, Inc., dated June 7, 2023
License Agreements
Candel Therapeutics, Inc.
Biotechnology
2023
Exclusive Patent License Agreement by and between Advantagene, Inc. and The Brigham and Womens Hospital, Inc. dated September 15, 2020
License Agreements
Candel Therapeutics, Inc.
Biotechnology
MA
2021
Exclusive License Agreement by and between Advantagene, Inc. and Ventagen, LLC dated March 1, 2014
License Agreements
Candel Therapeutics, Inc.
Biotechnology
NY
2021
Exclusive Patent License Agreement by and between Advantagene, Inc. and The Brigham and Womens Hospital, Inc. dated September 15, 2020
License Agreements
Candel Therapeutics, Inc.
Biotechnology
MA
2021
Exclusive License Agreement by and between Advantagene, Inc., d/b/a Candel Therapeutics and Periphagen, Inc. dated December 9, 2019
License Agreements
Candel Therapeutics, Inc.
Biotechnology
DE
2021
Exclusive License Agreement by and between Advantagene, Inc. and Ventagen, LLC dated March 1, 2014
License Agreements
Candel Therapeutics, Inc.
Biotechnology
NY
2021